Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Intravenous iron therapy in heart failure: a different perspective.

Ghafourian K, Chang HC, Ardehali H.

Eur J Heart Fail. 2019 Jun;21(6):703-714. doi: 10.1002/ejhf.1434. Epub 2019 Mar 18. No abstract available.

PMID:
30884037
2.

Late onset heart failure after childhood chemotherapy.

Hilfiker-Kleiner D, Ardehali H, Fischmeister R, Burridge P, Hirsch E, Lyon AR.

Eur Heart J. 2019 Mar 7;40(10):798-800. doi: 10.1093/eurheartj/ehz046. No abstract available.

PMID:
30753420
3.

Hepatic HKDC1 Expression Contributes to Liver Metabolism.

Pusec CM, De Jesus A, Khan MW, Terry AR, Ludvik AE, Xu K, Giancola N, Pervaiz H, Daviau Smith E, Ding X, Harrison S, Chandel NS, Becker TC, Hay N, Ardehali H, Cordoba-Chacon J, Layden BT.

Endocrinology. 2019 Feb 1;160(2):313-330. doi: 10.1210/en.2018-00887.

PMID:
30517626
4.

Metabolic Suppression of HIF-1α Contributes to Susceptibility of Ischemic Injury in Diabetic Hearts.

De Jesus A, Chang HC, Ardehali H.

JACC Basic Transl Sci. 2018 Aug 28;3(4):499-502. doi: 10.1016/j.jacbts.2018.07.001. eCollection 2018 Aug. No abstract available.

5.

Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21.

Sawicki KT, Chang HC, Shapiro JS, Bayeva M, De Jesus A, Finck BN, Wertheim JA, Blackshear PJ, Ardehali H.

JCI Insight. 2018 Jul 12;3(13). pii: 95948. doi: 10.1172/jci.insight.95948.

6.

mRNA-binding protein tristetraprolin is essential for cardiac response to iron deficiency by regulating mitochondrial function.

Sato T, Chang HC, Bayeva M, Shapiro JS, Ramos-Alonso L, Kouzu H, Jiang X, Liu T, Yar S, Sawicki KT, Chen C, Martínez-Pastor MT, Stumpo DJ, Schumacker PT, Blackshear PJ, Ben-Sahra I, Puig S, Ardehali H.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6291-E6300. doi: 10.1073/pnas.1804701115. Epub 2018 Jun 18.

7.

Hippocampal GABAA antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated rats.

Neugebauer NM, Miyauchi M, Sato T, Tadano J, Akal H, Ardehali H, Meltzer HY.

Behav Brain Res. 2018 Apr 16;342:11-18. doi: 10.1016/j.bbr.2017.12.033. Epub 2017 Dec 28.

PMID:
29289597
8.

Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.

Miyauchi M, Neugebauer NM, Sato T, Ardehali H, Meltzer HY.

J Psychopharmacol. 2017 Dec;31(12):1588-1604. doi: 10.1177/0269881117731278. Epub 2017 Sep 25.

PMID:
28946779
9.

Corrigendum: Snf1-related kinase improves cardiac mitochondrial efficiency and decreases mitochondrial uncoupling.

Rines AK, Chang HC, Wu R, Sato T, Khechaduri A, Kouzu H, Shapiro J, Shang M, Burke MA, Abdelwahid E, Jiang X, Chen C, Rawlings TA, Lopaschuk GD, Schumacker PT, Abel ED, Ardehali H.

Nat Commun. 2017 Aug 30;8:16155. doi: 10.1038/ncomms16155.

10.

Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2.

Yang X, Park SH, Chang HC, Shapiro JS, Vassilopoulos A, Sawicki KT, Chen C, Shang M, Burridge PW, Epting CL, Wilsbacher LD, Jenkitkasemwong S, Knutson M, Gius D, Ardehali H.

J Clin Invest. 2017 Apr 3;127(4):1505-1516. doi: 10.1172/JCI88574. Epub 2017 Mar 13.

11.

Potential consequences of the immigration ban on the scientific community.

Ardehali H.

J Clin Invest. 2017 Mar 1;127(3):735-736. doi: 10.1172/JCI93276. Epub 2017 Feb 8.

12.

Snf1-related kinase improves cardiac mitochondrial efficiency and decreases mitochondrial uncoupling.

Rines AK, Chang HC, Wu R, Sato T, Khechaduri A, Kouzu H, Shapiro J, Shang M, Burke MA, Abdelwahid E, Jiang X, Chen C, Rawlings TA, Lopaschuk GD, Schumacker PT, Abel ED, Ardehali H.

Nat Commun. 2017 Jan 24;8:14095. doi: 10.1038/ncomms14095. Erratum in: Nat Commun. 2017 Aug 30;8:16155.

13.

Iron and Sex Cross Paths in the Heart.

Shapiro JS, Chang HC, Ardehali H.

J Am Heart Assoc. 2017 Jan 23;6(1). pii: e005459. doi: 10.1161/JAHA.116.005459. No abstract available.

14.

Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron.

Chang HC, Shapiro JS, Ardehali H.

Circ Res. 2016 Nov 11;119(11):1164-1166. doi: 10.1161/CIRCRESAHA.116.309746. Review. No abstract available.

15.

Correction: Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.

Jia Y, Chang HC, Schipma MJ, Liu J, Shete V, Liu N, Sato T, Thorp EB, Barger PM, Zhu YJ, Viswakarma N, Kanwar YS, Ardehali H, Thimmapaya B, Reddy JK.

PLoS One. 2016 Sep 30;11(9):e0164316. doi: 10.1371/journal.pone.0164316. eCollection 2016.

16.

Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.

Jia Y, Chang HC, Schipma MJ, Liu J, Shete V, Liu N, Sato T, Thorp EB, Barger PM, Zhu YJ, Viswakarma N, Kanwar YS, Ardehali H, Thimmapaya B, Reddy JK.

PLoS One. 2016 Aug 22;11(8):e0160755. doi: 10.1371/journal.pone.0160755. eCollection 2016. Erratum in: PLoS One. 2016 Sep 30;11(9):e0164316.

17.

Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association.

Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW 2nd, Kitsis RN, Otsu K, Ping P, Rizzuto R, Sack MN, Wallace D, Youle RJ; American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Functional Genomics and Translational Biology.

Circ Res. 2016 Jun 10;118(12):1960-91. doi: 10.1161/RES.0000000000000104. Epub 2016 Apr 28. Review.

18.

The Good Neighbor: Coping With Insulin Resistance by Modulating Adipose Tissue Endothelial Cell Function.

Yar S, Chang HC, Ardehali H.

Circ Res. 2016 Mar 4;118(5):776-8. doi: 10.1161/CIRCRESAHA.116.308338. No abstract available.

19.

Reduction in mitochondrial iron alleviates cardiac damage during injury.

Chang HC, Wu R, Shang M, Sato T, Chen C, Shapiro JS, Liu T, Thakur A, Sawicki KT, Prasad SV, Ardehali H.

EMBO Mol Med. 2016 Mar 1;8(3):247-67. doi: 10.15252/emmm.201505748.

20.

Association of the Adductor Pollicis Muscle Thickness With Clinical Outcomes in Intensive Care Unit Patients.

Ghorabi S, Ardehali H, Amiri Z, Vahdat Shariatpanahi Z.

Nutr Clin Pract. 2016 Aug;31(4):523-6. doi: 10.1177/0884533615621547. Epub 2016 Feb 11.

PMID:
26869610
21.

"Targeting the Heart" in Heart Failure: Myocardial Recovery in Heart Failure With Reduced Ejection Fraction.

Wilcox JE, Fonarow GC, Ardehali H, Bonow RO, Butler J, Sauer AJ, Epstein SE, Khan SS, Kim RJ, Sabbah HN, Díez J, Gheorghiade M.

JACC Heart Fail. 2015 Sep;3(9):661-9. doi: 10.1016/j.jchf.2015.04.011. Review.

22.

Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury.

Sawicki KT, Shang M, Wu R, Chang HC, Khechaduri A, Sato T, Kamide C, Liu T, Naga Prasad SV, Ardehali H.

J Am Heart Assoc. 2015 Jul 31;4(8):e002272. doi: 10.1161/JAHA.115.002272.

23.

Role of heme in cardiovascular physiology and disease.

Sawicki KT, Chang HC, Ardehali H.

J Am Heart Assoc. 2015 Jan 5;4(1):e001138. doi: 10.1161/JAHA.114.001138. Review. No abstract available.

24.

Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy.

Wu R, Chang HC, Khechaduri A, Chawla K, Tran M, Chai X, Wagg C, Ghanefar M, Jiang X, Bayeva M, Gonzalez F, Lopaschuk G, Ardehali H.

J Clin Invest. 2014 Nov;124(11):4795-806. doi: 10.1172/JCI76737. Epub 2014 Oct 20.

25.

Short communication: high cellular iron levels are associated with increased HIV infection and replication.

Chang HC, Bayeva M, Taiwo B, Palella FJ Jr, Hope TJ, Ardehali H.

AIDS Res Hum Retroviruses. 2015 Mar;31(3):305-12. doi: 10.1089/aid.2014.0169. Epub 2014 Oct 7.

26.

Molecular and cellular basis of viable dysfunctional myocardium.

Bayeva M, Sawicki KT, Butler J, Gheorghiade M, Ardehali H.

Circ Heart Fail. 2014 Jul;7(4):680-91. doi: 10.1161/CIRCHEARTFAILURE.113.000912. Review. No abstract available.

27.

Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.

Kiczak L, Tomaszek A, Bania J, Paslawska U, Zacharski M, Janiszewski A, Rybinska I, Dziegiel P, von Haehling S, Ardehali H, Jankowska EA, Ponikowski P.

J Physiol Pharmacol. 2014 Jun;65(3):365-75.

28.

How to write a successful grant application and research paper.

Ardehali H.

Circ Res. 2014 Apr 11;114(8):1231-4. doi: 10.1161/CIRCRESAHA.114.303695. No abstract available.

PMID:
24723655
29.

Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.

Hohl M, Ardehali H, Azuaje FJ, Breckenridge RA, Doehner W, Eaton P, Ehret GB, Fujita T, Gaetani R, Giacca M, Hasenfuß G, Heymans S, Leite-Moreira AF, Linke WA, Linz D, Lyon A, Mamas MA, Orešič M, Papp Z, Pedrazzini T, Piepoli M, Prosser B, Rizzuto R, Tarone G, Tian R, van Craenenbroeck E, van Rooij E, Wai T, Weiss G, Maack C.

Eur J Heart Fail. 2014 Jan;16(1):6-14. doi: 10.1002/ejhf.10. Epub 2013 Dec 14. Review. No abstract available.

30.

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.

Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad SV, Mutharasan RK, Naik TJ, Ardehali H.

J Clin Invest. 2014 Feb;124(2):617-30. doi: 10.1172/JCI72931. Epub 2014 Jan 2.

31.

Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.

Bayeva M, Sawicki KT, Ardehali H.

J Am Heart Assoc. 2013 Nov 25;2(6):e000433. doi: 10.1161/JAHA.113.000433. Review. No abstract available.

32.

Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation.

Pachel C, Mathes D, Bayer B, Dienesch C, Wangorsch G, Heitzmann W, Lang I, Ardehali H, Ertl G, Dandekar T, Wajant H, Frantz S.

PLoS One. 2013 Nov 11;8(11):e78938. doi: 10.1371/journal.pone.0078938. eCollection 2013.

33.

When less is more: novel mechanisms of iron conservation.

Bayeva M, Chang HC, Wu R, Ardehali H.

Trends Endocrinol Metab. 2013 Nov;24(11):569-77. doi: 10.1016/j.tem.2013.07.003. Epub 2013 Aug 12. Review.

34.

Changes in parasympathetic system in medulla oblongata in male pigs in the course of tachycardia-induced cardiomyopathy.

Tomaszek A, Kiczak L, Bania J, Krupa P, Pasławska U, Zacharski M, Janiszewski A, Stefaniak T, Zyśko D, Ardehali H, Jankowska EA, Ponikowski P.

Auton Neurosci. 2013 Oct;177(2):253-9. doi: 10.1016/j.autneu.2013.05.010. Epub 2013 Jul 23.

PMID:
23891249
35.

ATP-binding cassette B10 regulates early steps of heme synthesis.

Bayeva M, Khechaduri A, Wu R, Burke MA, Wasserstrom JA, Singh N, Liesa M, Shirihai OS, Langer NB, Paw BH, Ardehali H.

Circ Res. 2013 Jul 19;113(3):279-87. doi: 10.1161/CIRCRESAHA.113.301552. Epub 2013 May 29.

36.

Expression and complex formation of MMP9, MMP2, NGAL, and TIMP1 in porcine myocardium but not in skeletal muscles in male pigs with tachycardia-induced systolic heart failure.

Kiczak L, Tomaszek A, Bania J, Paslawska U, Zacharski M, Noszczyk-Nowak A, Janiszewski A, Skrzypczak P, Ardehali H, Jankowska EA, Ponikowski P.

Biomed Res Int. 2013;2013:283856. doi: 10.1155/2013/283856. Epub 2013 Apr 22.

37.

MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes.

Qiao A, Khechaduri A, Kannan Mutharasan R, Wu R, Nagpal V, Ardehali H.

J Am Heart Assoc. 2013 Apr 22;2(2):e000121. doi: 10.1161/JAHA.113.000121.

38.

Heme levels are increased in human failing hearts.

Khechaduri A, Bayeva M, Chang HC, Ardehali H.

J Am Coll Cardiol. 2013 May 7;61(18):1884-93. doi: 10.1016/j.jacc.2013.02.012. Epub 2013 Mar 6.

39.

Mitochondria as a therapeutic target in heart failure.

Bayeva M, Gheorghiade M, Ardehali H.

J Am Coll Cardiol. 2013 Feb 12;61(6):599-610. doi: 10.1016/j.jacc.2012.08.1021. Epub 2012 Dec 5. Review.

40.

Iron status in patients with chronic heart failure.

Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD, Gheorghiade M, Ponikowski P.

Eur Heart J. 2013 Mar;34(11):827-34. doi: 10.1093/eurheartj/ehs377. Epub 2012 Nov 23.

41.

Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine.

Marcovina SM, Sirtori C, Peracino A, Gheorghiade M, Borum P, Remuzzi G, Ardehali H.

Transl Res. 2013 Feb;161(2):73-84. doi: 10.1016/j.trsl.2012.10.006. Epub 2012 Nov 5. Review.

42.

mTOR regulates cellular iron homeostasis through tristetraprolin.

Bayeva M, Khechaduri A, Puig S, Chang HC, Patial S, Blackshear PJ, Ardehali H.

Cell Metab. 2012 Nov 7;16(5):645-57. doi: 10.1016/j.cmet.2012.10.001. Epub 2012 Oct 25.

43.

Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin.

Rines AK, Burke MA, Fernandez RP, Volpert OV, Ardehali H.

FASEB J. 2012 Nov;26(11):4685-95. doi: 10.1096/fj.12-212282. Epub 2012 Aug 8.

44.

A new pROM king for the mitoK(ATP) dance: ROMK takes the lead.

Rines AK, Bayeva M, Ardehali H.

Circ Res. 2012 Aug 3;111(4):392-3. doi: 10.1161/CIRCRESAHA.112.275461. No abstract available.

45.

Transition metals and mitochondrial metabolism in the heart.

Rines AK, Ardehali H.

J Mol Cell Cardiol. 2013 Feb;55:50-7. doi: 10.1016/j.yjmcc.2012.05.014. Epub 2012 Jun 2. Review.

46.

Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production.

Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, Epting CL, Ardehali H.

EMBO Mol Med. 2012 Jul;4(7):633-46. doi: 10.1002/emmm.201200240. Epub 2012 Apr 20.

47.

Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export.

Ichikawa Y, Bayeva M, Ghanefar M, Potini V, Sun L, Mutharasan RK, Wu R, Khechaduri A, Jairaj Naik T, Ardehali H.

Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4152-7. doi: 10.1073/pnas.1119338109. Epub 2012 Feb 28.

48.

Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M.

Eur J Heart Fail. 2012 Feb;14(2):120-9. doi: 10.1093/eurjhf/hfr173. Review.

49.

microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.

Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H.

Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1519-30. doi: 10.1152/ajpheart.01080.2010. Epub 2011 Aug 12.

50.

Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis.

Smeele KM, Southworth R, Wu R, Xie C, Nederlof R, Warley A, Nelson JK, van Horssen P, van den Wijngaard JP, Heikkinen S, Laakso M, Koeman A, Siebes M, Eerbeek O, Akar FG, Ardehali H, Hollmann MW, Zuurbier CJ.

Circ Res. 2011 May 13;108(10):1165-9. doi: 10.1161/CIRCRESAHA.111.244962. Epub 2011 Apr 28.

PMID:
21527739

Supplemental Content

Loading ...
Support Center